Cargando…
A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine
Our knowledge about the clinical spectrum of COVID-19 has continued to evolve. The clinical features of the infection and vaccine are continuously updated. We present a case of bullous pemphigoid after receiving a second dose of the COVID-19 vaccine. This case highlights autoimmune skin findings see...
Autores principales: | Nida, Syeda S, Tobon, Gabriel J, Wilson, Morgan, Chauhan, Krati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621734/ https://www.ncbi.nlm.nih.gov/pubmed/36340561 http://dx.doi.org/10.7759/cureus.29786 |
Ejemplares similares
-
Development of High-Grade Sarcoma After Second Dose of Moderna Vaccine
por: Bae, Edward, et al.
Publicado: (2023) -
Bullous Iodide Rash
Publicado: (1909) -
A Case of Prostate Cancer Presenting with Rash
por: Albawaliz, Anas, et al.
Publicado: (2019) -
A Case of Leg Pain After the Initial Dose of the COVID-19 Vaccine, Followed by Deep Vein Thrombosis and Pulmonary Embolism After the Second Dose
por: Nagao, Michiru, et al.
Publicado: (2023) -
Eosinophilic Granulomatosis With Polyangiitis Diagnosed in an Elderly Female After the Second Dose of mRNA Vaccine Against COVID-19
por: Ibrahim, Hanan, et al.
Publicado: (2022)